Literature DB >> 31725416

Acute Fatty Liver of Pregnancy.

David B Nelson1, John J Byrne, F Gary Cunningham.   

Abstract

Acute fatty liver of pregnancy (AFLP) is a rare, but potentially fatal condition, characterized by hepatic failure typically in the third trimester of pregnancy that is associated with multiorgan involvement resulting in a number of clinical and laboratory abnormalities. The cornerstone of management of AFLP includes prompt recognition, preparation for delivery, and supportive care such as reversal of coagulopathy. Early diagnosis, prompted delivery, and supportive care have resulted in improved maternal morbidity and mortality. This review focuses on the epidemiology, etiology, clinical presentation, diagnosis, management, and resolution of AFLP.

Entities:  

Mesh:

Year:  2020        PMID: 31725416     DOI: 10.1097/GRF.0000000000000494

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  4 in total

1.  How to evaluate and treat the spectrum of TMA syndromes in pregnancy.

Authors:  Marie Scully
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Managing hepatic complications of pregnancy: practical strategies for clinicians.

Authors:  Maura Alice Morrison; Yooyun Chung; Michael A Heneghan
Journal:  BMJ Open Gastroenterol       Date:  2022-03

3.  Timely identification and successful treatment of acute fatty liver of pregnancy without obvious clinical symptoms: Case reports.

Authors:  Weiping Cao; Tingmei Chen; Wen Jiang; Yinping Geng; Bing Xie; Qin Wang; Xinzhi Wang
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.817

4.  Accurate Prediction of Total PlGF (Placental Growth Factor) From Free PlGF and sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1): Evidence for Markedly Elevated PlGF Levels in Women With Acute Fatty Liver of Pregnancy.

Authors:  Rugina I Neuman; Langeza Saleh; Koen Verdonk; Anton H van den Meiracker; Henk Russcher; Herold J Metselaar; Willy Visser; A H Jan Danser
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 10.190

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.